Indexed with PubMed and Science Citation Index (E) 
Users online: 2853 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal


Year : 1980  |  Volume : 46  |  Issue : 6  |  Page : 338--340

A Clinical Trial of "B-663" in Vitiligo

Correspondence Address:
Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

'B663' (3-P chloranilino) - 10 (P-Chlorophenyl) - 2, 10-dihydro-2-(ISO-prophylimino) (lampre-ne, Hansepran) was tried in 20 pmknts with vitiligo. Majority of cam (I 7) did not show any improvement Three cases showed slight repigmentation. Generalised dark brown pigmentation was a major deterrent for the patients to use this drug. Good results claimed in a previous report, could not be substantiated by us.


Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow